Skip to main content
    PeptideAuthority
    Fact-checked by the Peptide Authority Editorial Board · Last reviewed:
    Share:X PostLinkedIn
    Healing & Recovery•Updated 2026-02-01•6 min read

    What Is GHK-Cu? Benefits, Research & Safety

    A naturally occurring copper-binding tripeptide researched for its roles in wound healing, skin regeneration, anti-ageing, and tissue remodelling.

    Share:X PostLinkedIn
    Also known as:
    Copper Peptide GHK
    GHK Copper Complex
    Glycyl-L-Histidyl-L-Lysine:Copper(II)
    CLimited human evidenceUK: Sold as 'research only' (UK)WADA: Low sport risk

    UK summary: Naturally occurring tripeptide-copper complex. Topical cosmetic formulations are regulated under UK cosmetics legislation; injectable forms are research-only and unlicensed. Genuine cosmetic evidence exists for topical skin and hair endpoints; injectable claims should be assessed separately.

    Quick Facts

    Category
    Healing & Recovery
    Half-Life
    Variable depending on formulation; plasma half-life of unbound GHK-Cu is relatively short
    UK Status
    Available as a cosmetic ingredient. Injectable forms not licensed for therapeutic use.
    EU Status
    Approved cosmetic ingredient. Not authorised as a medicinal product.

    Overview

    GHK-Cu (Glycyl-L-Histidyl-L-Lysine:Copper(II)) is a naturally occurring tripeptide composed of three amino acids—glycine, histidine, and lysine—bound to a copper ion. This copper peptide is found naturally in human plasma, saliva, and urine, with plasma levels declining significantly with age. First identified in 1973, GHK-Cu has been extensively researched for its remarkable biological activities, particularly in the context of wound healing, tissue regeneration, and skin health. The peptide demonstrates an ability to stimulate collagen synthesis, promote angiogenesis, and modulate the activity of numerous genes involved in tissue repair and regeneration. What makes GHK-Cu particularly interesting is its role as a biological signal that triggers tissue remodelling. Research suggests it can reset gene expression patterns in damaged tissue toward a healthier, more regenerative state. Studies have identified over 4,000 genes whose expression may be modulated by GHK-Cu. The copper component is not merely structural but functionally important. Copper ions play essential roles in numerous enzymatic processes including collagen cross-linking, antioxidant defence, and cellular energy production. GHK-Cu is available commercially in various skincare products and has also been researched in injectable forms. While topical formulations are widely available, injectable forms remain primarily in the research domain.
    Evidence standards summary

    GHK-Cu — evidence and risk at a glance

    Twenty standard modules scored against the Peptide Authority evidence grading methodology. Missing modules indicate the field has not yet been characterised editorially — treat absences as uncertainty rather than reassurance.

    01Evidence snapshot

    CLimited human evidenceOverall grade against our evidence grading methodology.

    Naturally occurring tripeptide-copper complex. Topical cosmetic formulations are regulated under UK cosmetics legislation; injectable forms are research-only and unlicensed. Genuine cosmetic evidence exists for topical skin and hair endpoints; injectable claims should be assessed separately.

    02Human evidence grade

    CLimited human evidenceStrength of evidence from published human trials.

    03Preclinical evidence grade

    BModerate human evidenceAnimal-model and in-vitro evidence quality.

    04Regulatory status

    • UK: Available as a cosmetic ingredient. Injectable forms not licensed for therapeutic use.
    • EU: Approved cosmetic ingredient. Not authorised as a medicinal product.
    • Notes: GHK-Cu is widely used in cosmetic formulations and is generally considered safe for topical use. Injectable forms remain in the research domain and are not approved for therapeutic use.

    05Approved medical uses

    • No UK-licensed finished medicine; topical cosmetic formulations regulated under UK cosmetics rules, not medicines law.

    06Unapproved / promotional claims

    • Injectable GHK-Cu reverses ageing systemically
    • Heals injury and stimulates hair regrowth via injection
    • Gene-expression ‘reset’ proven in humans

    07Common internet claims

    • Same effect topical vs injectable
    • Pharma-grade copper peptide reverses biological age
    • Replaces dermatologist care for skin ageing

    08Claim vs evidence

    ClaimEvidenceHuman evidence?Regulatory concernSafer wording
    “Topical GHK-Cu improves skin firmness and reduces wrinkles”CYesLowSeveral small human trials of topical GHK-Cu show improvements in skin appearance metrics; effect sizes vary by formulation.
    “Injectable GHK-Cu regenerates tissue and reverses ageing”DNoHighMechanistic and animal-model evidence; human injectable evidence is limited and unlicensed in the UK.
    “Reverses hair loss”CLimitedModerateSome topical hair-growth studies are encouraging; effect size is modest and the formulation matters.

    09Safety uncertainty score

    Moderate

    Safety profile partly characterised; some signals from observational or preclinical data.

    10Known adverse signals

    • Topical: mild irritation in sensitive individuals (uncommon).
    • Injectable: limited UK safety data; sterility risk from grey-market vials.
    • Copper-overload theoretical risk with long-term systemic use.

    11Drug-interaction uncertainty

    Moderate

    Some interaction data published; check with a prescriber for your specific medicines.

    12Anti-doping status

    WADA: Low sport riskWADA strict-liability framing applies.

    13UK legal position

    UK: Sold as 'research only' (UK)

    Available as a cosmetic ingredient. Injectable forms not licensed for therapeutic use.

    Read the full UK legal guide → Are peptides legal in the UK?

    14EU legal position

    Approved cosmetic ingredient. Not authorised as a medicinal product.

    15What this page cannot tell you

    • Whether topical or injectable is appropriate for your skin or condition.
    • Whether an injectable vial purchased online contains what it claims.
    • Long-term safety of injectable GHK-Cu (largely uncharacterised).
    • How injectable use interacts with other medicines or skin conditions.

    16Last reviewed

    Last reviewed:

    Next review due:

    Spotted an error or something out of date? Send a correction.

    17Citation quality score

    BModerate human evidenceQuality of the sources we cite, graded against the evidence grading methodology.

    18Research gaps

    • No large human RCTs of injectable GHK-Cu for any indication.
    • Comparative efficacy of injectable vs topical not characterised in humans.
    • Long-term safety of systemic copper-peptide exposure.

    19Safer alternatives / established care pathways

    • Clinically-validated topical cosmetic formulations.
    • Dermatologist-led plans for skin ageing or hair-loss concerns.
    • Licensed treatments for specific dermatology indications (e.g. minoxidil, retinoids).

    Related Safety Centre page → Unlicensed peptide risks

    20Doctor discussion prompts

    Questions to ask a qualified clinician

    These are starter questions you can adapt for a GP, specialist, pharmacist, or anti-doping advisor. The aim is to help you have a better-informed conversation — not to replace one.

    • Is the form I'm asking about topical (cosmetic) or injectable (unlicensed research)?
    • What does the human evidence actually support for the indication I have?
    • Are there licensed UK alternatives for my dermatology concern?

    Discovery & History

    GHK-Cu was first isolated from human plasma in 1973 by Dr. Loren Pickart during research into factors that could reverse liver damage. The tripeptide was found to stimulate the synthesis of collagen and other matrix proteins by hepatocytes, leading to further investigation of its biological properties. Throughout the 1980s and 1990s, research expanded to explore GHK-Cu's effects on wound healing and skin regeneration. Studies demonstrated that the peptide could accelerate wound closure, increase collagen synthesis, and promote new blood vessel formation at injury sites. The discovery that GHK-Cu could stimulate hair follicle growth further expanded interest in its potential applications. Clinical studies in the 1990s showed improvements in skin texture, elasticity, and firmness when GHK-Cu was applied topically. In the 2000s, gene array studies revealed that GHK-Cu modulates the expression of thousands of genes, many involved in tissue repair, antioxidant responses, and anti-inflammatory pathways. This broad gene-regulatory activity helped explain the peptide's diverse biological effects. GHK-Cu has been incorporated into numerous commercial skincare products, making it one of the few peptides with widespread availability in cosmetic formulations. Research continues into its potential therapeutic applications beyond cosmetic use.

    Mechanism of Action

    GHK-Cu exerts its biological effects through multiple mechanisms, with its gene-regulatory activity being particularly significant: **Gene Expression Modulation** GHK-Cu acts as a biological signal that can modulate the expression of approximately 31% of human genes. It tends to reset gene expression toward a more youthful, regenerative pattern. Key affected pathways include those involved in: - Antioxidant and anti-inflammatory responses - Tissue remodelling and repair - DNA repair mechanisms - Stem cell support **Collagen Synthesis Stimulation** The peptide significantly enhances the production of collagen types I, III, and IV by fibroblasts. This increased collagen production is fundamental to wound healing and skin structural integrity. GHK-Cu also promotes the synthesis of other matrix proteins including decorin and elastin. **Angiogenesis Promotion** GHK-Cu stimulates the formation of new blood vessels, enhancing blood supply to healing tissues. This improved vascularisation supports nutrient delivery and waste removal essential for tissue repair. **Anti-Inflammatory Effects** The peptide modulates inflammatory responses, potentially reducing excessive inflammation that can impair healing. It appears to shift macrophage activity toward a more reparative phenotype. **Antioxidant Activity** GHK-Cu has demonstrated antioxidant properties, both directly through copper-mediated reactions and indirectly through upregulation of antioxidant enzyme genes. This protects tissues from oxidative damage during healing. **Matrix Metalloproteinase Regulation** GHK-Cu modulates the activity of matrix metalloproteinases and their inhibitors, promoting orderly tissue remodelling rather than excessive matrix degradation or scar formation.

    Researched Benefits

    Based on preclinical and clinical research findings:

    • 1
      Accelerated wound healing with improved tissue quality in multiple studies
    • 2
      Increased collagen and elastin synthesis for improved skin structure
    • 3
      Enhanced skin elasticity, firmness, and thickness
    • 4
      Reduced appearance of fine lines and wrinkles in clinical studies
    • 5
      Potential hair growth stimulation and follicle support
    • 6
      Anti-inflammatory effects that may benefit various conditions
    • 7
      Antioxidant activity protecting tissues from oxidative damage
    • 8
      Possible neuroprotective effects under investigation

    Claim vs Evidence

    How popular claims about GHK-Cu stack up against the current research, graded using our public evidence grading methodology.

    ClaimEvidenceHuman evidence?Regulatory concernSafer wording
    “Topical GHK-Cu improves skin firmness and reduces wrinkles”CYesLowSeveral small human trials of topical GHK-Cu show improvements in skin appearance metrics; effect sizes vary by formulation.
    “Injectable GHK-Cu regenerates tissue and reverses ageing”DNoHighMechanistic and animal-model evidence; human injectable evidence is limited and unlicensed in the UK.
    “Reverses hair loss”CLimitedModerateSome topical hair-growth studies are encouraging; effect size is modest and the formulation matters.

    Theoretical Dosing & Protocols

    ⚠️ Educational Only: The following information is derived from research literature and is not a prescription or recommendation. No standardised human dosing exists. Always consult a qualified healthcare professional.
    Theoretical DosageTopical: 1-3% in formulations; Injectable: highly variable in research settings
    FrequencyTopical applications typically once or twice daily
    DurationVariable depending on application; skin improvements often observed over 8-12 weeks
    NotesTopical GHK-Cu is widely available in commercial skincare products. Injectable forms remain primarily in research settings. The optimal delivery system and concentration may vary by application. Consult a dermatologist for personalised skincare recommendations.

    Administration Routes

    Routes studied in research settings (educational only):

    • Topical application (most common, available in commercial products)
    • Subcutaneous injection (research settings)
    • Intradermal injection (research settings)
    Half-LifeStability
    Variable depending on formulation; plasma half-life of unbound GHK-Cu is relatively shortStable in appropriate formulations; copper peptide complexes can be sensitive to certain conditions

    Safety Profile & Known Risks

    Commonly Reported Side Effects

    • Mild skin irritation with topical application in some individuals
    • Temporary redness at application site
    • Possible allergic reactions in sensitive individuals

    Rare Risks & Concerns

    • Allergic reactions to copper or peptide components
    • Theoretical concerns regarding copper accumulation with excessive use
    • Unknown long-term effects of injectable forms in humans

    Contraindications

    • Known allergy to copper or peptide components
    • Wilson's disease (impaired copper metabolism)
    • Pregnancy and breastfeeding (precautionary)
    • Active skin infections at application site

    UK & EU Regulatory Context

    🇬🇧 United Kingdom

    Available as a cosmetic ingredient. Injectable forms not licensed for therapeutic use.

    🇪🇺 European Union

    Approved cosmetic ingredient. Not authorised as a medicinal product.

    GHK-Cu is widely used in cosmetic formulations and is generally considered safe for topical use. Injectable forms remain in the research domain and are not approved for therapeutic use.

    Clinical Studies Summary

    The Human Tripeptide GHK-Cu in the Prevention of Oxidative Stress and Degenerative Conditions

    Review of GHK-Cu's antioxidant properties and potential applications in age-related conditions.

    Oxid Med Cell Longev. 2012View on PubMed

    Effects of topical copper tripeptide complex on CO2 laser-resurfaced skin.

    Copper tripeptide complex (GHK-Cu) skin care products placed on CO(2) laser-resurfaced skin offered no significant reduction or resolution of posttreatment erythema. Objective evaluation found no significant improvement in wrinkles or overall skin quality. However, patient satisfaction was significantly higher for those who used GHK-Cu skin care products after CO(2) laser skin resurfacing.

    Arch Facial Plast Surg. 2006View on PubMed

    Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.

    While peptide therapy may possess significant therapeutic and regenerative potential, it is critical that orthopaedic and sports medicine providers understand the current lack of evidence to support the clinical use of these peptides. Importantly, information regarding the indications, dosing, frequency, and duration of treatment remains unknown.

    Am J Sports Med. 2026View on PubMed

    Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?

    An analysis of the literature data reveals that the transport of liposomes containing GHK-Cu received little attention. This research gap gives an impetus to the methodological developments for assessing the effect of liposomes on GHK-Cu transportation and trafficking.

    Molecules. 2025View on PubMed

    Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data.

    GHK has also been found to possess powerful cell protective actions, such as multiple anti-cancer activities and anti-inflammatory actions, lung protection and restoration of chronic obstructive pulmonary disease (COPD) fibroblasts, suppression of molecules thought to accelerate the diseases of aging such as NFκB, anti-anxiety, anti-pain and anti-aggression activities, DNA repair, and activation of cell cleansing via…

    Int J Mol Sci. 2018View on PubMed

    The human tri-peptide GHK and tissue remodeling.

    GHK-Cu also improves hair transplant success, protects hepatic tissue from tetrachloromethane poisoning, blocks stomach ulcer development, and heals intestinal ulcers and bone tissue. These results are beginning to define the complex biochemical processes that regulate tissue remodeling.

    J Biomater Sci Polym Ed. 2008View on PubMed

    Registered Trials & Regulatory Status

    Registered trials
    1
    Currently recruiting
    1
    Furthest phase
    Phase 2
    Approved product
    No

    Topical GHK-Cu Gel for Acute Skin Wound Healing

    PHASE2

    Status: Recruiting · 60 participants · Hudson Biotech

    Conditions: Acute Standardized Cutaneous Wounds (Punch-biopsy Wounds)

    No results postedNCT07437586

    Adverse event reports (FDA FAERS)

    Not applicable: no licensed product contains this peptide, so it is not reported through FAERS. This is an absence of surveillance, not evidence of safety.

    Source: ClinicalTrials.gov and openFDA. Updated automatically.

    Looking for GHK-Cu?

    Source research-grade GHK-Cu from a trusted UK supplier — third-party tested with certificate of analysis.

    View at Supplier

    Frequently Asked Questions

    Questions to ask a qualified clinician about GHK-Cu

    These are starter questions you can adapt for a GP, specialist, pharmacist, or anti-doping advisor. The aim is to help you have a better-informed conversation — not to replace one.

    • Is the form I'm asking about topical (cosmetic) or injectable (unlicensed research)?
    • What does the human evidence actually support for the indication I have?
    • Are there licensed UK alternatives for my dermatology concern?

    UK regulatory & safety context

    Are peptides legal in the UK?

    UK legal reference

    Unlicensed peptide risks

    Safety Centre guide

    Related Research Guides

    Peptides for Skin Health

    Read guide

    Peptides for Anti-Ageing

    Read guide

    Peptides for Tendon Injuries

    Read guide

    Peptides for Hair Growth

    Read guide

    Peptides for Joint Health

    Read guide

    Peptides for Wrinkle Reduction

    Read guide

    Peptides for Skin Firmness

    Read guide

    Peptide Comparisons

    BPC-157 vs GHK-Cu

    Compare peptides

    TB-500 vs GHK-Cu

    Compare peptides

    Matrixyl vs GHK-Cu

    Compare peptides

    Argireline vs GHK-Cu

    Compare peptides

    Combination Protocols

    BPC-157 + GHK-Cu Skin Healing Stack

    View protocol

    BPC-157 + GHK-Cu Gut Healing Stack

    View protocol

    GHK-Cu + Matrixyl + Argireline Anti-Ageing Stack

    View protocol

    GHK-Cu + Matrixyl Collagen Synergy Stack

    View protocol

    GHK-Cu + Matrixyl + BPC-157 Triple-Pathway Collagen Stack

    View protocol

    Related Peptides

    BPC-157

    A pentadecapeptide derived from human gastric juice, extensively researched for its potential tissue repair and regenerative properties across multiple organ systems.

    Learn more

    TB-500

    A synthetic version of the naturally occurring peptide Thymosin Beta-4, extensively researched for its roles in tissue repair, cell migration, and angiogenesis.

    Learn more

    Matrixyl

    A pioneering signal peptide that mimics natural collagen-boosting messengers, extensively validated in clinical studies for wrinkle reduction and skin firmness improvement.

    Learn more

    Argireline

    A neuromodulating hexapeptide that reduces facial muscle contractions through SNARE complex inhibition, providing a topical alternative to botulinum toxin for expression line reduction.

    Learn more

    Syn-Ake

    A tripeptide that mimics the neuromuscular blocking effects of Temple Viper venom (waglerin-1), targeting nicotinic acetylcholine receptors to reduce expression lines.

    Learn more

    Epitalon

    A synthetic tetrapeptide based on epithalamin, researched for its potential effects on telomerase activation and biological ageing.

    Learn more

    Explore More Peptides

    Browse our comprehensive database of research-backed peptide profiles.